Icagen, Inc. — Form D
Icagen, Inc. of DURHAM, NC, a company, filed a Form D exempt-offering notice with the SEC on 2018-04-12. The offering totals $4.0M, of which $2.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2018-04-12
- Form: D
- Accession: 0001213900-18-004354
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $4.0M
- Amount sold: $2.0M
- Remaining: $2.0M
- Minimum investment: $100K
- Investors: 1
- Date of first sale: 2018-04-04
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-310047
Issuer
- Name: Icagen, Inc.
- CIK: 0001518520
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 4222 EMPEROR BLVD., SUITE 350, DURHAM, NC, 27703
- Phone: 919-941-5206
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Douglas Krafte | Director | Oro Valley, AZ |
| Vincent Palmieri | Director | Larchmont, NY |
| MICHAEL TAGLICH | Director | SAN RAMON, CA |
| Richard Cunningham | Executive Officer | Lakeway, TX |
| Mark Korb | Executive Officer | Sherman Oaks, CA |
| Timothy Tyson | Director | Oro Valley, AZ |
| Douglas Krafte | Executive Officer | Oro Valley, AZ |
| Edward Roffman | Director | Durham, NC |
| Clive Kabatznik | Director | Durham, NC |
| Benjamin Warner | Director | Durham, NC |
| Benjamin Warner | Executive Officer | Durham, NC |
| Jeremiel Zimmerman | Director | Los Alamos, NM |
Other filings by this issuer (10)
More